Total liver RNA from mice injected with adenovirus (109 pfu per mouse) encoding apoC-III variants or empty vector was isolated with TriPure reagent (Roche), as per the manufacturer’s instructions. After removal of genomic DNA, the first-strand cDNA synthesis was performed by using a QuantiNova reverse transcription kit (Qiagen), and the template cDNA was diluted 1:20 with nuclease-free water. Relative mRNA expression was determined by quantitative RT-PCR using inventoried TaqMan assays (Srebf1; Mm00550338_m1, Srebf2; Mm01306292_m1, Fas; Mm00662319_m1, Scd1; Mm00772290_m1, Acc1; Mm00728460_s1, Acc2; Mm00624282_m1, Cd36; Mm00432403_m1, Hmgcr; Mm01282499_m1, Ldlr; Mm01177349_m1, Tbp; Mm00446973_m1, Pparg; Mm00440940_m1, Nr1h3 [liver X receptor a (LXRa)]; Mm00443451_m1, and βactin; Mm00607939_s1) combined with QuantiNova Probe PCR mix (Qiagen) on a Rotor-Gene-Q instrument (Qiagen). Relative expression was determined by using the ΔΔCt method (17), normalized to the average of both Tbp and βactin, and data were presented relative to vector control samples.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.